Funding pharmaceutical innovation through direct tax credits

E-ISSN： 1744-134x|2|3|267-284

ISSN： 1744-1331

Source： Health Economics, Policy and Law, Vol.2, Iss.3, 2007-07, pp. : 267-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Income tax credits and exemptions

By Lambert P.J. Yitzhaki S.

European Journal of Political Economy, Vol. 13, Iss. 2, 1997-05 ,pp. : 343-351

Elsevier

Access to resources Recommend Favorite

Tax credits, labour participation and home production in the Netherlands

By Mastrogiacomo Mauro Bosch Nicole

Applied Economics, Vol. 43, Iss. 23, 2011-09 ,pp. : 3115-3128

Routledge Ltd

Access to resources Recommend Favorite

Market size and pharmaceutical innovation

THE RAND JOURNAL OF ECONOMICS, Vol. 46, Iss. 4, 2015-10 ,pp. : 844-871

John Wiley & Sons Inc

Access to resources Recommend Favorite

The welfare gain from replacing the health insurance tax exclusion with lump-sum tax credits

By Liu Liqun

International Journal of Health Care Finance and Economics, Vol. 11, Iss. 2, 2011-06 ,pp. : 101-113

Springer Publishing Company

Access to resources Recommend Favorite

Did Medicare Induce Pharmaceutical Innovation?

By Acemoglu Daron Cutler David Finkelstein Amy Linn Joshua

The American Economic Review, Vol. 96, Iss. 2, 2006-05 ,pp. : 103-107

American Economic Association

Access to resources Recommend Favorite